1995
DOI: 10.1016/0378-5173(94)00366-d
|View full text |Cite
|
Sign up to set email alerts
|

Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
29
0
1

Year Published

2004
2004
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 72 publications
(31 citation statements)
references
References 6 publications
0
29
0
1
Order By: Relevance
“…But during storage nucleation and recrystallization of a crystalline drug takes place in solid dispersions [82] . Furthermore, there are many other pitfalls which also requires a profound studies and it include the inability to scale up the solid dosage formulation from a small scale melt quench or a solvent-evaporation technique, insufficient knowledge of the mechanism of dissolution of drug from the dosage form, prevention of crystallization of some drug which takes place in the gastric fluids and the poor understanding of the in vitro-in vivo correlation between these dosage forms [83,84] .…”
Section: Amorphous Contentmentioning
confidence: 99%
“…But during storage nucleation and recrystallization of a crystalline drug takes place in solid dispersions [82] . Furthermore, there are many other pitfalls which also requires a profound studies and it include the inability to scale up the solid dosage formulation from a small scale melt quench or a solvent-evaporation technique, insufficient knowledge of the mechanism of dissolution of drug from the dosage form, prevention of crystallization of some drug which takes place in the gastric fluids and the poor understanding of the in vitro-in vivo correlation between these dosage forms [83,84] .…”
Section: Amorphous Contentmentioning
confidence: 99%
“…Therefore, the favorable effect obtained can be attributed mainly to the improved drug wettability and decrease of aggregation phenomena as a consequence of a reduced interfacial tension between drug particles and dissolution media (Sheen et al 1995). In addition, the concomitant particle size reduction and consequent increase of the effective surface area exposed to the dissolution medium, as well as the intimate and fine dispersion of the drug into the hydrophilic polymer, obtained by virtue of the melting preparation method, can contribute further to the better performance of such systems.…”
Section: Resultsmentioning
confidence: 99%
“…The ideal type of solid dispersion for increasing dissolution is a glassy solution, in which the drug in the amorphous form has a lower thermodynamic barrier to dissolution and a maximally reduced particle size (Goldberg et al, 1965). In addition, the incorporation of a hydrophilic excipient and/or surface-active agent can increase wetting and lead to supersaturation in the diffusion layer (Serajuddin et al, 1988;Morris et al, 1992;Sheen et al, 1995). Solid solutions and dispersions are most commonly formed either from a drug/excipient mixture via solvent casting, melt extrusion, or spray-drying techniques (Corrigan et al, 1985;Forster et al, 2001).…”
Section: Solid Dispersionmentioning
confidence: 99%